Transparency Market Research
Several global manufacturers plan to introduce innovative and technologically advanced products in the market and these innovations have presented numerous opportunities for the growth of the neonatal peripherally inserted central venous catheter market, offering easy use of vascular access devices associated with increasing patient safety. Vygon S. A. provides a range of improvised polyurethane PICC catheters such as Premicath injectable catheters, Nutriline, and Premistar. Pregnancy complications such as multiple births are associated with an increased risk of preterm delivery, low birth weight, and other associated high-risk morbidities. This increases demand for NICU services. Newborn infections and birth asphyxia account for over 80% of all global neonatal deaths. This has created a need for early diagnosis and appropriate treatment in hospitals, which in turn has increased NICU admissions. These factors contribute to the growth of the global neonatal peripherally inserted central venous catheter market. Safer and advanced catheter insertion systems, and availability of trained technicians due to rise in adoption of PICC line are expected to fuel the growth of the global market. The cost of vascular access device and its maintenance forms a crucial economic factor in the long-term management of complications. Neonatal intensive care is extremely expensive causing financial burden both on the family and the health care system.
The global neonatal peripherally inserted central venous catheter market can be segmented based on type of PICC, end-user, and region. In terms of type, the market can be bifurcated into powered and conventional PICCs. The powered PICCs made up of polyurethane expected to grow due to comparatively high efficiency and easy insertion and removal while surgeries. Based on end-user, the global neonatal peripherally inserted central venous catheter market can be categorized into hospitals, specialty clinics, and others. The hospitals segment is expected to be driven by high demand for vascular access devices in hospitals across the globe.
The global neonatal peripherally inserted central venous catheter market can be segmented into five key regions: Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America is expected to account for significant share of the global neonatal peripherally inserted central venous catheter market due to developed health care infrastructure, rise in number of premature births, and high adoption of PICC lines for vascular access. Europe was the second largest market for neonatal peripherally inserted central venous catheters in 2017. India, China, and Japan are the major markets for neonatal peripherally inserted central venous catheters in Asia Pacific.
The global neonatal peripherally inserted central venous catheter market is highly consolidated, with small number of companies accounting for more than 60% share. Major players in the global market include C. R. Bard, Inc., Argon Medical, Teleflex Incorporated, Medical Components, Inc., Vygon S.A., Cook Medical Inc., and AngioDynamics, Inc.
MRR.BIZ has been compiled in-depth market research data in the report after exhaustive primary and secondary research. Our team of able, experienced in-house analysts has collated the information through personal interviews and study of industry databases, journals, and reputable paid sources.
The report provides the following information:
The main aim of the report is to:
MRR.BIZ is a leading provider of strategic market research. Our vast repository consists research reports, data books, company profiles, and regional market data sheets. We regularly update the data and analysis of a wide-ranging products and services around the world. As readers, you will have access to the latest information on almost 300 industries and their sub-segments. Both large Fortune 500 companies and SMEs have found those useful. This is because we customize our offerings keeping in mind the specific requirements of our clients.